Quoin Pharmaceuticals Ltd... (QNRX)
NASDAQ: QNRX
· Real-Time Price · USD
7.50
0.20 (2.67%)
At close: Aug 15, 2025, 3:34 PM
7.48
-0.20%
After-hours: Aug 15, 2025, 04:04 PM EDT
Quoin Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.67M | 3.82M | 3.62M | 3.12M | 2.85M | 1.83M | 2.4M | 3.16M | 4.76M | 3.37M | 2.86M | 5.25M | 2.69M | 5.19M | 7.48M | 652.79K | 1.72M | 1.08M |
Short-Term Investments | 6.12M | 7.73M | 10.43M | 7.19M | 9.73M | 12.86M | 8.29M | 10.82M | 10.68M | 13.62M | 9.99M | 9.91M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 114.16K | n/a |
Other Long-Term Assets | n/a | n/a | 300K | 383.39K | 300K | 300K | 300K | 300K | 383.39K | 383.39K | 383.39K | 50K | 50K | 50K | 50K | 50K | 50K | 245.66K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -350.16K | n/a |
Other Current Assets | 6.12M | n/a | n/a | n/a | n/a | 4.00 | 4.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 305.92K | 253.15K | n/a |
Total Current Assets | 8.48M | 12.5M | 14.93M | 10.5M | 13.22M | 15.26M | 11.29M | 14.14M | 15.67M | 17.39M | 13.37M | 15.66M | 3.51M | 6M | 8.5M | 958.71K | 2.02M | 1.13M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 475.68K | n/a |
Goodwill & Intangibles | 433.33K | 458.33K | 483.33K | 508.33K | 533.33K | 558.33K | 583.33K | 626.53K | 652.54K | 678.55K | 704.56K | 730.57K | 756.58K | 782.59K | 808.6K | 834.62K | 860.63K | 886.64K |
Total Long-Term Assets | 433.33K | 458.33K | 783.33K | 891.72K | 833.34K | 858.34K | 883.34K | 926.53K | 1.04M | 1.06M | 1.09M | 780.57K | 806.58K | 832.59K | 858.6K | 884.62K | 910.63K | 1.13M |
Total Assets | 8.91M | 12.96M | 15.71M | 11.39M | 14.05M | 16.12M | 12.17M | 15.07M | 16.71M | 18.45M | 14.46M | 16.44M | 4.32M | 6.83M | 9.36M | 1.84M | 2.93M | 2.26M |
Account Payables | 873.68K | 644.06K | 905.7K | 222.64K | 819.67K | 358.51K | 526.52K | 239.98K | 707.93K | 281.09K | 605.6K | 280.7K | 768.67K | 214.68K | 923.24K | 517.79K | 403.81K | 234.87K |
Deferred Revenue | n/a | n/a | n/a | n/a | -600K | -600K | -600 | -600 | -725 | -650 | -600 | -600 | -600 | -600K | -736.44M | 6.8M | 165.23K | n/a |
Short-Term Debt | n/a | 600K | 600K | 600K | 600K | 600K | 600K | 600K | n/a | n/a | n/a | n/a | n/a | 600K | 743.84M | 6.21M | 6.21M | 3.21M |
Other Current Liabilities | 2.73M | -600K | 2M | 79.95K | 600.01K | 600.03K | 94.61K | 166.21K | 924.41K | 803.55K | 759.59K | 753.55K | 753.55K | 200K | -742.62M | 1.4M | 1.4M | 2.9M |
Total Current Liabilities | 4.34M | 4.86M | 4.18M | 3.47M | 3.95M | 4.22M | 3.58M | 4.58M | 4.41M | 4.16M | 3.53M | 3.6M | 3.67M | 3.59M | 8.7M | 13.57M | 13.11M | 10.32M |
Long-Term Debt | n/a | n/a | n/a | n/a | 2.62M | 2.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.97M | 4.12M | n/a | n/a | 2.45M |
Other Long-Term Liabilities | 2.02M | 2.17M | 2.32M | 2.47M | 2.62M | 2.77M | 2.92M | 3.07M | 3.22M | 3.37M | 3.52M | 3.67M | 3.82M | n/a | 7.03B | 4.52M | 4.61M | n/a |
Total Long-Term Liabilities | 2.02M | 2.17M | 2.32M | 2.47M | 2.62M | 2.77M | 2.92M | 3.07M | 3.22M | 3.37M | 3.52M | 3.67M | 3.82M | 3.97M | 7.03B | 4.52M | 4.67M | 2.45M |
Total Liabilities | 6.36M | 7.03M | 6.5M | 5.95M | 6.58M | 7M | 6.51M | 7.65M | 7.64M | 7.54M | 7.05M | 7.27M | 7.49M | 7.56M | 8.7M | 18.1M | 17.78M | 12.77M |
Total Debt | n/a | 2.77M | 2.92M | 3.07M | 3.22M | 3.37M | 3.52M | 3.67M | 3.95K | 4.02K | 4.12K | 4.27K | 4.42K | 4.57M | 743.84M | 6.21M | 6.21M | 5.66M |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.00 | n/a | n/a | n/a | 100.00 | 100.00 | 100.00 |
Retained Earnings | -62.67M | -58.98M | -55.17B | -52.85M | -50.5M | -48.53M | -46.2M | -44.15M | -42.23M | -40.12M | -37.52M | -35.52M | -32.42M | -29.75M | -28.07M | -16.25M | -14.85M | -10.51M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | n/a | 5.2M | n/a |
Shareholders Equity | 2.55M | 5.93M | 9.2M | 5.44M | 7.48M | 9.13M | 5.66M | 7.41M | 9.07M | 10.91M | 7.41M | 9.17M | -3.17M | -729.41K | 657.03K | -16.25M | -14.85M | -10.51M |
Total Investments | 6.12M | 7.73M | 10.43M | 7.19M | 9.73M | 12.86M | 8.29M | 10.82M | 10.68M | 13.62M | 9.99M | 9.91M | n/a | n/a | n/a | n/a | 114.16K | n/a |